Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
Background The clinical utility of malignant pleural effusion (MPE) to detect mutation has been well documented; however, routine practice of the use of MPE involves collection of the cell pellet to detect mutation, and limited studies have interrogated the MPE supernatant as an alternative source o...
Main Authors: | Zhihua Guo, Zhanhong Xie, Huifang Shi, Wei Du, Lijun Peng, Wei Han, Feidie Duan, Xin Zhang, Mingyan Chen, Junli Duan, Jing Lin, Xuewei Chen, Analyn Ang Lizaso, Han Han‐Zhang, Jianxing He, Weiqiang Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-04-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13006 |
Similar Items
-
Management of dyspnea and respiratory insufficiency as a main palliayive care in malignant pleural effusions
by: D. Valchev, et al.
Published: (2017-09-01) -
Next-Generation Sequencing of Cell-Free DNA Extracted From Pleural Effusion Supernatant: Applications and Challenges
by: Ami Patel, et al.
Published: (2021-06-01) -
Malignant pleural effusion: current understanding and therapeutic approach
by: Francesca Gonnelli, et al.
Published: (2024-01-01) -
Research progress of tumor‐derived extracellular vesicles in the treatment of malignant pleural effusion
by: Sijia Zhang, et al.
Published: (2023-01-01) -
Malignant pleural effusion: Updates in diagnosis, management and current challenges
by: Dinesh Narayan Addala, et al.
Published: (2022-11-01)